![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/soligenix-announces-positive-clinical-results-from-a-comparative-study-evaluating-hybryte-against-valchlor-in-the-treatment-of-cutaneous-t-cell-lymphoma-302181378.html
https://www.globenewswire.com/news-release/2022/09/01/2508251/0/en/Helsinn-Healthcare-SA-signs-exclusive-license-agreement-with-Juniper-Biologics-Pte-Ltd-for-LEDAGA-chlormethine-in-Australia-Asia-and-the-Middle-East.html
https://www.thepharmaletter.com/article/helsinn-signs-exclusive-license-deal-with-juniper-biologics
https://globenewswire.com/news-release/2018/12/20/1670176/0/en/RECORDATI-AND-HELSINN-AGREEMENT-FOR-THE-EXCLUSIVE-COMMERCIALIZATION-RIGHTS-TO-LEDAGA.html
https://www.pharmacompass.com/pdf/news/actelion-registration-ledaga-chlormethine-receives-approval-in-europe-1489748556.pdf